参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 海萝胶 | HCID 313 | — |
| 反应物 | 乙酐 | HCID 7918 | — |
| 反应物 | L-Thyroxine monosodium salt | HCID 23666112 | — |
| 溶剂 | 乙醇 | HCID 702 | — |
| 溶剂 | 聚[6-[4-(4-氰基苯基)苯氧基]己基甲基丙烯酸酯] | HCID 962 | — |
| 溶剂 | N,N-二甲基甲酰胺 | HCID 6228 | — |
| 溶剂 | 二甲基对苯二胺二盐酸 | HCID 14798 | — |
| 产物 | N-乙酰基L-甲状腺素 | HCID 20638380 | 90% |
反应步骤
L-Thyroxine sodium salt, pentahydrate (1) (10 g, 11 mmol) was nearly completely dissolved in 400 mL of EtOH/2N NH4OH (1/1, v/v), filtered, and filtrate poured into 425 mL of 5% HCl. The resulting precipitate was isolated by vacuum filtration and dried under high vacuum to afford a white solid. This material was dissolved in 160 mL DMF, 100 mL (1.06 mol) of acetic anhydride added, and reaction stirred for 1.5 hours, then diluted with 850 mL H2O and allowed to stand at 4° C. for 16 hours. The resulting precipitate was isolated by filtration, then dissolved in 350 mL EtOH and 41 mL of 1N NaOH, stirred for 2.5 hours, 680 mL of 5% HCl added, and mixture allowed to stand at 4° C. for 16 hours. The resulting precipitate was isolated by vacuum filtration and dried under high vacuum to yield 8.1 g (90%) of the desired N-acetyl L-thyroxine (5) as a white solid; 1H NMR (200 MHz, CD3OD) d 7.8 (s, 2H), 7.1 (s, 2H), 4.6-4.7 (m, 1H), 2.8-3.0 (m, 2H), 2.0 (s, 3H); mass spec (FAB) (M+H)+ 820.
来源与证据
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 专利号 | US05593896 |
|---|
| 来源数据集 | uspto-grants-1997_01 |
|---|
| ORD ID | ord-97e385cdd7e44f0396ea95960748bd36 |
|---|
| 来源说明 | uspto-grants-1997_01 |
|---|